These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17981040)

  • 21. Anti-alkaline phosphatase antibody positive myasthenia gravis.
    Konishi T; Ohta K; Shigemoto K; Ohta M
    J Neurol Sci; 2007 Dec; 263(1-2):89-93. PubMed ID: 17628604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anesthetic considerations for thymectomy in a patient having an anti-acetylcholine receptor antibody without myasthenia gravis].
    Koshida T; Hara K; Obara G; Sata T
    Masui; 2008 Aug; 57(8):993-5. PubMed ID: 18710007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term effect of intravenous immunoglobulin on anti-MuSK antibody-positive myasthenia gravis.
    Shibata-Hamaguchi A; Samuraki M; Furui E; Iwasa K; Yoshikawa H; Hayashi S; Yamada M
    Acta Neurol Scand; 2007 Dec; 116(6):406-8. PubMed ID: 17986100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis.
    Ponseti JM; Azem J; Fort JM; López-Cano M; Vilallonga R; Buera M; Cervera C; Armengol M
    Neurology; 2005 May; 64(9):1641-3. PubMed ID: 15883336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency of seronegativity in adult-acquired generalized myasthenia gravis.
    Chan KH; Lachance DH; Harper CM; Lennon VA
    Muscle Nerve; 2007 Nov; 36(5):651-8. PubMed ID: 17654558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonresponsiveness to anticholinesterase agents in patients with MuSK-antibody-positive MG.
    Hatanaka Y; Hemmi S; Morgan MB; Scheufele ML; Claussen GC; Wolfe GI; Oh SJ
    Neurology; 2005 Nov; 65(9):1508-9. PubMed ID: 16275854
    [No Abstract]   [Full Text] [Related]  

  • 27. MuSK Ab described in seropositive MG sera found to be Ab to alkaline phosphatase.
    Ohta K; Shigemoto K; Kubo S; Maruyama N; Abe Y; Ueda N; Fujinami A; Ohta M
    Neurology; 2005 Dec; 65(12):1988. PubMed ID: 16380629
    [No Abstract]   [Full Text] [Related]  

  • 28. A sensitive non-isotopic assay for acetylcholine receptor autoantibodies.
    Hewer R; Matthews I; Chen S; McGrath V; Evans M; Roberts E; Nute S; Sanders J; Furmaniak J; Smith BR
    Clin Chim Acta; 2006 Feb; 364(1-2):159-66. PubMed ID: 16051208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expansion of circulating counterparts of follicular helper T cells in patients with myasthenia gravis.
    Luo C; Li Y; Liu W; Feng H; Wang H; Huang X; Qiu L; Ouyang J
    J Neuroimmunol; 2013 Mar; 256(1-2):55-61. PubMed ID: 23305745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between myasthenia gravis-activities of daily living (MG-ADL) and quantitative myasthenia gravis (QMG) assessments of anti-acetylcholine receptor antibody-positive refractory generalized myasthenia gravis in the phase 3 regain study.
    Vissing J; O'Brien F; Wang JJ; Howard JF
    Muscle Nerve; 2018 Aug; 58(2):E21-E22. PubMed ID: 29684239
    [No Abstract]   [Full Text] [Related]  

  • 31. High interleukin-10 production is associated with anti-acetylcholine receptor antibody production and treatment response in juvenile myasthenia gravis.
    Yapici Z; Tüzün E; Altunayoğlu V; Erdoğan A; Eraksoy M
    Int J Neurosci; 2007 Nov; 117(11):1505-12. PubMed ID: 17917921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical study of double filtration plasmapheresis for treatment of refractory myasthenia gravis].
    Huo JT; Long HL; Luo X; Xu JZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):355-7. PubMed ID: 17425991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myasthenia gravis: a clinical review.
    Burke WJ
    Clin Exp Neurol; 1981; 17():1-14. PubMed ID: 7346191
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of FK506 on myasthenia gravis patients with high interleukin-2 productivity in peripheral blood mononuclear cells.
    Utsugisawa K; Nagane Y; Yonezawa H; Obara D; Kondoh R; Tohgi H
    Muscle Nerve; 2003 Feb; 27(2):245-8. PubMed ID: 12548534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MuSK antibody clearance during serial sessions of plasmapheresis for myasthenia gravis.
    Yeh JH; Chen WH; Chiu HC; Bai CH
    J Neurol Sci; 2007 Dec; 263(1-2):191-3. PubMed ID: 17602704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness and safety of tacrolimus therapy for myasthenia gravis: A single arm meta-analysis.
    Wang L; Xi J; Zhang S; Wu H; Zhou L; Lu J; Zhang T; Zhao C
    J Clin Neurosci; 2019 May; 63():160-167. PubMed ID: 30827886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigen-specific apheresis of pathogenic autoantibodies from myasthenia gravis sera.
    Tzartos SJ; Bitzopoulou K; Gavra I; Kordas G; Jacobson L; Kostelidou K; Lagoumintzis G; Lazos O; Poulas K; Sideris S; Sotiriadis A; Trakas N; Zisimopoulou P
    Ann N Y Acad Sci; 2008; 1132():291-9. PubMed ID: 18567880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical statistics of myasthenia gravis in Japan.
    Uono MI
    Int J Neurol; 1980; 14(1):87-99. PubMed ID: 6983511
    [No Abstract]   [Full Text] [Related]  

  • 40. Anti-CD20 antibody (Rituximab) therapy in a myasthenia gravis patient with follicular lymphoma.
    Takagi K; Yoshida A; Iwasaki H; Inoue H; Ueda T
    Ann Hematol; 2005 Aug; 84(8):548-50. PubMed ID: 15871017
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.